<SEC-DOCUMENT>0001654954-17-005040-index.html : 20170524
<SEC-HEADER>0001654954-17-005040.hdr.sgml : 20170524
<ACCEPTANCE-DATETIME>20170524102258
ACCESSION NUMBER:		0001654954-17-005040
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170629
FILED AS OF DATE:		20170524
DATE AS OF CHANGE:		20170524
EFFECTIVENESS DATE:		20170524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NAVIDEA BIOPHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000810509
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				311080091
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35076
		FILM NUMBER:		17865695

	BUSINESS ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147937500

	MAIL ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEOPROBE CORP
		DATE OF NAME CHANGE:	19940714
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>navb_def-14a.htm
<DESCRIPTION>DEFINITIVE 14A
<TEXT>
Document 1 - file: navb_def-14a.htm

</DOCUMENT>
</SEC-DOCUMENT>